M. Tiemann

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?

A. Ganser, V. Grünwald, C. Reuter, 2022, World Journal of Urology.

[Castleman's disease in the rheumatological practice].

O. Sander, B. Manger, J. Henes, 2023, Zeitschrift fur Rheumatologie.